amlashbispecificsbloodcancerscarecellchangingchicagoclinicalcllcmlcontroversiescostdahiyadatadiscussdiscussesdiseasedlbcldrseditorendpointsevolutionfellowsfollicularfrontlinefuturehighhighlightshodgkininnovationsinsidelatestlivelymphomamalignanciesmanagementmbbsmdmdsmmmphmpnmrdmyelomanewsnextnhlquestionquestionsrealrevolutionrisksaysshadmansohospecialspiegeltellstherapiestherapytimetreatingtreatmenttrialsunansweredupdatesususmanivenugopalworld